During the past decade, Sunderby Sjukhus Medicinkliniken conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sunderby Sjukhus Medicinkliniken" #1 collaborator was "Pharmacyclics LLC." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Sunderby Sjukhus Medicinkliniken" are "Leukemia, Lymphocytic, Chronic, B-Cell" (1 trials) and "Smoldering Multiple Myeloma" (1 trials). Many other conditions were trialed in "Sunderby Sjukhus Medicinkliniken" in a lesser frequency.

Most popular intervention types in "Sunderby Sjukhus Medicinkliniken" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Chlorambucil" (1 trials), "Daratumumab SC: daratumumab + rHuPH20" (1 trials), "Ibrutinib" (1 trials), "Ibrutinib (as Subsequent Therapy)" (1 trials) and "Obinutuzumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Sunderby Sjukhus Medicinkliniken" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Sunderby Sjukhus Medicinkliniken". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Sunderby Sjukhus Medicinkliniken, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Sunderby Sjukhus Medicinkliniken, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".